Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/OMI · Entity 6858 | Director | May 15, 2025 | May 16, 2025 |
| ILLUMINA, INC.ILMN · Entity 3137 | SVP, Chief Information Officer | April 05, 2025 | April 08, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date May 15, 2025 · Filed May 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 53,902 |
Reported balance
After 2025-05-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-05-15 · Grant · Acquired 28,914 · Balance 53,902 F1: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date.
ILLUMINA, INC.
Report date April 05, 2025 · Filed April 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,447 |
Reported balance
After 2025-04-05 transaction · row 1
1 source rowRow 1 · 2025-04-05 · Tax withholding · Disposed 113 · Balance 18,447 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2025 Filed May 16, 2025 22:11 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 28,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-009729 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,902 F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. Read SEC document |
| April 05, 2025 Filed Apr 8, 2025 20:06 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 113 | $73.45 | $8,299.85 |
DisclosureSEC source: 0001127602-25-011807 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,447 Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:14 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantPerformance Shares · Derivative | 8,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008696 · form4.xml · derivative · entry 3 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,496 Underlying: Common Stock · 8,496 shares Expires 2028-01-02 F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending January 2, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending January 2, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F4 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending January 2, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending January 2, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:14 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantPerformance Shares · Derivative | 8,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008696 · form4.xml · derivative · entry 2 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,496 Underlying: Common Stock · 8,496 shares Expires 2028-01-02 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average operating margin for fiscal years 2025-2027 with vesting on January 2, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average operating margin for fiscal years 2025-2027, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average operating margin for fiscal years 2025-2027 with vesting on January 2, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average operating margin for fiscal years 2025-2027, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:14 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 7,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008696 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,560 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2026, February 15, 2027, February 15, 2028, and February 15, 2029, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 192 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 15, 2025 Filed Feb 20, 2025 02:48 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 513 | $101.09 | $51,859.17 |
DisclosureSEC source: 0001127602-25-005777 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,085 Read SEC document |
| November 05, 2024 Filed Nov 8, 2024 00:43 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 412 | $154.96 | $63,843.52 |
DisclosureSEC source: 0001127602-24-026776 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,598 F1 · balance_after: Balance includes 62 shares acquired through Employee Stock Purchase Plan. F2 · balance_after: In connection with Illumina's spin out of Grail, Inc., which was completed on June 24, 2024, all unvested equity award units were adjusted pursuant to Illumina's Amended and Restated 2015 Stock and Incentive Plan. Ms. Rollin's unvested RSUs were increased by 202 units as a result of such adjustment. Read SEC document |
| May 09, 2024 Filed May 10, 2024 20:07 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 11,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009888 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,988 F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. Read SEC document |
| April 05, 2024 Filed Apr 10, 2024 21:16 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 122 | $127.75 | $15,585.50 |
DisclosureSEC source: 0001127602-24-012778 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,746 Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:29 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantPerformance Shares · Derivative | 6,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009037 · form4.xml · derivative · entry 3 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,497 Underlying: Common Stock · 6,497 shares Expires 2027-01-03 F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending January 3, 2027. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending January 3, 2027, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F4 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending January 3, 2027. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending January 3, 2027, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:29 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantPerformance Shares · Derivative | 6,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009037 · form4.xml · derivative · entry 2 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,497 Underlying: Common Stock · 6,497 shares Expires 2027-01-03 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average operating margin for fiscal years 2024-2026 with vesting on January 3, 2027 . The number of shares issued will range from 0% to 200% of the amount specified above, based on the Company's actual three-year average operating margin for fiscal years 2024-2026 , relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average operating margin for fiscal years 2024-2026 with vesting on January 3, 2027 . The number of shares issued will range from 0% to 200% of the amount specified above, based on the Company's actual three-year average operating margin for fiscal years 2024-2026 , relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:29 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 5,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009037 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,868 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2025, February 15, 2026, February 15, 2027, and February 15, 2028, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 126 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| November 05, 2023 Filed Nov 8, 2023 01:01 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 404 | $112.84 | $45,587.36 |
DisclosureSEC source: 0001127602-23-026970 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,173 F1 · balance_after: Balance includes 80 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| May 12, 2023 Filed May 13, 2023 01:18 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 9,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-010998 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,834 F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. Read SEC document |
| April 05, 2023 Filed Apr 10, 2023 21:01 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 115 | $230.92 | $26,555.80 |
DisclosureSEC source: 0001127602-23-012778 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,497 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:28 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantPerformance Shares · Derivative | 3,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008589 · form4.xml · derivative · entry 3 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,023 Underlying: Common Stock · 3,023 shares Expires 2025-12-28 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:28 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantPerformance Shares · Derivative | 2,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008589 · form4.xml · derivative · entry 2 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,015 Underlying: Common Stock · 2,015 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:28 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 5,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008589 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,612 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| July 12, 2022 Filed Jul 13, 2022 20:42 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 4,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-016309 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,490 F1 · security: Restricted stock grant which vests in one year. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantPerformance Shares · Derivative | 4,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011724 · form4.xml · derivative · entry 2 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,123 Underlying: Common Stock · 4,123 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 1,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011724 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of April 5, 2023, April 5, 2024, April 5, 2025, and April 5, 2026, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.